Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel A Pryma

Showing results (71-80 of 124) with videos related to

Pageof 13
Sort By:
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|October 20, 2022
Potential clinical utility of <sup>68</sup>Ga-DOTATATE PET/CT for detection and response assessment in cardiac sarcoidosisHwan Lee, Erin K Schubert, Mahesh K Vidula, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 3, 2019
NANETS/SNMMI Procedure Standard for Somatostatin Receptor-Based Peptide Receptor Radionuclide Therapy with <sup>177</sup>Lu-DOTATATEThomas A Hope, Amanda Abbott, Karen Colucci, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 30, 2025
Influence of Subcellular Localization on the Cytotoxicity of Targeted α-TherapyHwan Lee, Swarbhanu Sarkar, Kexiang Xu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 29, 2019
PennPET Explorer: Human Imaging on a Whole-Body ImagerAustin R Pantel, Varsha Viswanath, Margaret E Daube-Witherspoon, et al.
Medicine|October 1, 2022
Perfusion-only imaging in pregnant women: A comparative reader study with implications for practice patternsJennifer A Schroeder, Quy Cao, Vlasios S Sotirchos, et al.
Circulation. Genomic and Precision Medicine|May 12, 2018
Frameshifts in Code and in Care: The Importance of Timely Genetic EvaluationNosheen Reza, Jessica L Chowns, Shana L Merrill, et al.
Cancer Research|June 5, 2016
A Radiotracer Strategy to Quantify PARP-1 Expression In Vivo Provides a Biomarker That Can Enable Patient Selection for PARP Inhibitor TherapyMehran Makvandi, Kuiying Xu, Brian P Lieberman, et al.
ACS Pharmacology & Translational Science|February 22, 2021
PARP Targeted Alpha-Particle Therapy Enhances Response to PD-1 Immune-Checkpoint Blockade in a Syngeneic Mouse Model of GlioblastomaHannah Dabagian, Tahereh Taghvaee, Paul Martorano, et al.
EJNMMI Research|March 24, 2025
A biorthogonal chemistry approach for high-contrast antibody imaging of lymphoma at early time pointsSwarbhanu Sarkar, Jonathan M Pham, Kimberly J Edwards, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 5, 2024
[<sup>18</sup>F]Fluorthanatrace PET in Ovarian Cancer: Comparison with [<sup>18</sup>F]FDG PET, Lesion Location, Tumor Grade, and Breast Cancer Gene Mutation StatusJoanna K Weeks, Austin R Pantel, Sarah B Gitto, et al.
Pageof 13

Showing results (71-80 of 124) with videos related to

Sort By:
Pageof 13
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|October 20, 2022
Potential clinical utility of <sup>68</sup>Ga-DOTATATE PET/CT for detection and response assessment in cardiac sarcoidosisHwan Lee, Erin K Schubert, Mahesh K Vidula, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 3, 2019
NANETS/SNMMI Procedure Standard for Somatostatin Receptor-Based Peptide Receptor Radionuclide Therapy with <sup>177</sup>Lu-DOTATATEThomas A Hope, Amanda Abbott, Karen Colucci, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 30, 2025
Influence of Subcellular Localization on the Cytotoxicity of Targeted α-TherapyHwan Lee, Swarbhanu Sarkar, Kexiang Xu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 29, 2019
PennPET Explorer: Human Imaging on a Whole-Body ImagerAustin R Pantel, Varsha Viswanath, Margaret E Daube-Witherspoon, et al.
Medicine|October 1, 2022
Perfusion-only imaging in pregnant women: A comparative reader study with implications for practice patternsJennifer A Schroeder, Quy Cao, Vlasios S Sotirchos, et al.
Circulation. Genomic and Precision Medicine|May 12, 2018
Frameshifts in Code and in Care: The Importance of Timely Genetic EvaluationNosheen Reza, Jessica L Chowns, Shana L Merrill, et al.
Cancer Research|June 5, 2016
A Radiotracer Strategy to Quantify PARP-1 Expression In Vivo Provides a Biomarker That Can Enable Patient Selection for PARP Inhibitor TherapyMehran Makvandi, Kuiying Xu, Brian P Lieberman, et al.
ACS Pharmacology & Translational Science|February 22, 2021
PARP Targeted Alpha-Particle Therapy Enhances Response to PD-1 Immune-Checkpoint Blockade in a Syngeneic Mouse Model of GlioblastomaHannah Dabagian, Tahereh Taghvaee, Paul Martorano, et al.
EJNMMI Research|March 24, 2025
A biorthogonal chemistry approach for high-contrast antibody imaging of lymphoma at early time pointsSwarbhanu Sarkar, Jonathan M Pham, Kimberly J Edwards, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 5, 2024
[<sup>18</sup>F]Fluorthanatrace PET in Ovarian Cancer: Comparison with [<sup>18</sup>F]FDG PET, Lesion Location, Tumor Grade, and Breast Cancer Gene Mutation StatusJoanna K Weeks, Austin R Pantel, Sarah B Gitto, et al.
Pageof 13